Shareholders approve all proposed resolutions of Novartis Board of Directors
Shareholders approve 14th consecutive dividend increase to CHF 2.20 (+5%) per share for 2010, representing a payout of approximately 55% of net income from continuing operations, marking continued increase in the dividend per share since the creation of Novartis in 1996 Enrico Vanni elected as new member of the Novartis Board of Directors for a three year term Mrs. Ann Fudge. Mr. Pierre Landolt and Ulrich Lehner re-elected to the Novartis Board of Directors for three year terms Novartis reaffirms Group outlook Basel, February 22, 2011 - Novartis shareholders today followed the Board of Directors' recommendations for all proposed resolutions at the Group's Annual General Meeting. Shareholders approved the fourteenth consecutive dividend increase of 5% to CHF 2.20 for 2010. A total of 2,160 shareholders were present at the meeting held in Basel, representing 1,23 shares or 46.5% of the 2,64 billion issued shares of Novartis. "2010 was shaped by repercussions from the global financial crisis and considerable currency turbulence. Despite these difficult conditions, Novartis was very successful. Our long-term strategy focused on innovation and an attractive business portfolio once more has produced excellent results.
